Invention Grant
- Patent Title: Composition for inhibition of cathepsin K
- Patent Title (中): 用于抑制组织蛋白酶K的组合物
-
Application No.: US11885421Application Date: 2006-02-24
-
Publication No.: US08722734B2Publication Date: 2014-05-13
- Inventor: Anastasia Daifotis , Selwyn Aubrey Stoch , Basil Avery Ince , Cameron Black
- Applicant: Anastasia Daifotis , Selwyn Aubrey Stoch , Basil Avery Ince , Cameron Black
- Applicant Address: US NJ Rahway CA Quebec
- Assignee: Merck Sharp & Dohme Corp.,Merck Canada Inc.
- Current Assignee: Merck Sharp & Dohme Corp.,Merck Canada Inc.
- Current Assignee Address: US NJ Rahway CA Quebec
- Agent Nicole M. Beeler; Catherine D. Fitch
- International Application: PCT/US2006/006622 WO 20060224
- International Announcement: WO2007/046842 WO 20070426
- Main IPC: A01N37/34
- IPC: A01N37/34
Abstract:
The present invention relates to the a method of inhibiting bone resorption in a mammal in need thereof with an oral pharmaceutical composition comprising a cathepsin K inhibitor, or a pharmaceutically acceptable salt thereof, or a mixture thereof, according to a continuous schedule having a dosage interval of once weekly, biweekly, twice monthly or once monthly.
Public/Granted literature
- US20080255072A1 Composition for Inhibition of Cathepsin K Public/Granted day:2008-10-16
Information query
